![Nessan Bermingham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nessan Bermingham
Gründer bei
Liberate Bio, Inc.
Vermögen: 438 574 $ am 31.08.2026
Profil
Dr. Nessan Bermingham is an Operating Partner at Khosla Ventures LLC, a Chairman at F-star Therapeutics Ltd., a Chairman at Korro Bio, Inc., a Chairman at F-star Biotechnology Ltd., an Executive Chairman at Korro Bio, Inc. (United States), a Member at Baylor College of Medicine and a President, Treasurer, Secretary & Director at Liberate Bio, Inc. He is on the Board of Directors at Deep Genomics, Inc., Charm Therapeutics Ltd. and Liberate Bio, Inc.
Dr. Bermingham was previously employed as a Chief Executive Officer by EveryONE Medicines, Inc., a Chairman by F-star Therapeutics, Inc., an Executive Chairman by Triplet Therapeutics, Inc., an Executive Chairman by Xilio Therapeutics, Inc., an Executive Chairman by F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH, a Venture Partner by Atlas Venture Advisors, Inc., a President, Chief Executive Officer & Director by Intellia Therapeutics, Inc., a Senior Advisor by Alnylam Pharmaceuticals, Inc., a Chief Executive Officer by Tal Medical, Inc., a Founder & Managing Partner by Bio Equity Capital LLC, a Partner by Omega Funds, an Analyst by UBS Warburg, Inc., a Non-Executive Director by Arrow Therapeutics Ltd., a Consultant by LAB International, Inc., a Board Member by Renovo Services LLC, and a Co-Founder by Serentis Ltd. He also served on the board at F-Star Therapeutics, Inc. (United States), F-star Alpha Ltd., F-Star Beta Ltd., F-Star Delta Ltd., Alliance for Regenerative Medicine, Cellzome Ltd., Navitor Pharmaceuticals, Inc., NsGene A/S and PreciSense A/S.
He received his undergraduate degree from Queen's University Belfast A.F.C.
and a doctorate degree from Imperial College London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,24 % | 10.06.2026 | 35.114 ( 0,24 % ) | 438 574 $ | 31.08.2026 |
Aktive Positionen von Nessan Bermingham
| Unternehmen | Position | Beginn |
|---|---|---|
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Vorsitzender | - |
Khosla Ventures LLC
 Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Private Equity Investor | 01.12.2021 |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Direktor/Vorstandsmitglied | - |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Direktor/Vorstandsmitglied | 06.01.2023 |
Liberate Bio, Inc.
 Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Gründer | - |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Gründer | - |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Vorsitzender | 10.09.2018 |
Ehemalige bekannte Positionen von Nessan Bermingham
| Unternehmen | Position | Ende |
|---|---|---|
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Vorstandsvorsitzender | 10.07.2024 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Nessan Bermingham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
35
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 35 |
|---|---|
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and manufactures drugs | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
Omega Funds
 Omega Funds Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Miscellaneous |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Operates as a clinical stage medical device company | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PreciSense A/S
 PreciSense A/S Electronic Equipment/InstrumentsElectronic Technology Develops and distributes non-invasive blood glucose monitoring systems | Electronic Technology |
Khosla Ventures LLC
Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Finance |
Serentis Ltd.
 Serentis Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and distributes pharmaceutical products | Health Technology |
Renovo Services LLC
 Renovo Services LLC Miscellaneous Commercial ServicesCommercial Services Provides repossession services | Commercial Services |
UBS Warburg, Inc. | |
Bio Equity Capital LLC
 Bio Equity Capital LLC Investment ManagersFinance Bio Equity Capital invests in middle market companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions with an investment size of more than USD 1 million. The firm makes follow-on investments. | Finance |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Health Technology |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
F-Star Delta Ltd.
 F-Star Delta Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody products to improve the treatment of serious diseases | Health Technology |
Queen's University Belfast A.F.C.
 Queen's University Belfast A.F.C. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Commercial Services |
Charm Therapeutics Ltd.
Charm Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
Liberate Bio, Inc.
Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
